The biotechnology company posted revenue of $758,000 in the period, topping Street forecasts. Four analysts surveyed by Zacks expected $743,000.
News
- BioTime: 4Q Earnings Snapshot
- Agenus: 4Q Earnings Snapshot
The biotechnology company posted revenue of $5.4 million in the period. For the year, the company reported that its loss widened to $162 million, ...
- Rutgers urges students to get meningitis vaccinations
Rutgers Biomedical and Health Sciences Chancellor Brian Strom says that while officials can't predict whether there will be new cases, tests from the ...
- CTI BioPharma: 4Q Earnings Snapshot
The biotechnology company posted revenue of $14.1 million in the period. For the year, the company reported that its loss narrowed to $29.3 million, ...
- A Harvard University R&D lab just picked up $100 million of hedge-fund cash
Harvard has launched more than 70 startups in the past five years, most of them life-sciences companies, university officials told The Boston Globe.